Reto Rufener
Reto Rufener received his PhD in Molecular Life Sciences in 2020 from the University of Bern in Switzerland. Before he joined the CETSA group in Stockholm, he was a scientist in the field of molecular parasitology. Within the scope of his previous work, he investigated the mode of action of various drugs and was developing new chemotherapeutic treatment options against infectious diseases targeting the energy metabolism. In his current project, he employs CETSA to describe the mechanism of action of new anti-cancer drugs within the cellular context. Moreover, he is developing a particular drug screening assay based on the findings of previous CETSA studies.